RYBIRTRA Trademark

Trademark Overview

On Tuesday, June 8, 2021, a trademark application was filed for RYBIRTRA with the United States Patent and Trademark Office. The USPTO has given the RYBIRTRA trademark a serial number of 90760541. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, September 11, 2024. This trademark is owned by Alexion Pharmaceuticals, Inc.. The RYBIRTRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological, autoimmune, dermatological, immunological and inflammatory related diseases and disorders; pharmaceutical preparations for the treatment of complement-mediated neurological diseases and disorders; none of the foregoing being pharmaceutical preparations for the treatment of sialorrhea
rybirtra

General Information

Serial Number90760541
Word MarkRYBIRTRA
Filing DateTuesday, June 8, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, September 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hematological, autoimmune, dermatological, immunological and inflammatory related diseases and disorders; pharmaceutical preparations for the treatment of complement-mediated neurological diseases and disorders; none of the foregoing being pharmaceutical preparations for the treatment of sialorrhea

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, August 28, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlexion Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameAlexion Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Friday, June 11, 2021NEW APPLICATION ENTERED
Saturday, August 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 25, 2022ASSIGNED TO EXAMINER
Monday, March 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 12, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, May 6, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, July 29, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, August 15, 2022ASSIGNED TO PETITION STAFF
Tuesday, August 16, 2022CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Sunday, August 21, 2022EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, October 4, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 10, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 10, 2023SOU EXTENSION 1 FILED
Friday, March 10, 2023SOU EXTENSION 1 GRANTED
Tuesday, March 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 4, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 6, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 6, 2023SOU EXTENSION 2 FILED
Wednesday, September 6, 2023SOU EXTENSION 2 GRANTED
Friday, September 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 4, 2024SOU EXTENSION 3 FILED
Monday, March 4, 2024SOU EXTENSION 3 GRANTED
Tuesday, March 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 24, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 24, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 24, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 11, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 11, 2024SOU EXTENSION 4 GRANTED
Wednesday, September 11, 2024SOU EXTENSION 4 FILED

Related Keywords

rybirtra pharmaceutical treatment preparations diseases disorders neurological foregoing sialorrhea being mediated